PayPoint plc : Director/PDMR Shareholding
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail24 November 2025
PayPoint Plc
(the "Company")
Director / PDMR Transaction
The Company announces that it has been notified that on 21 November 2025, Rob Harding, Chief Finance Officer, purchased 1,924 ordinary shares of 0.3611 pence each in the Company (‘’Ordinary Shares’’) at a price of 519 pence per share.
The notification of Dealing Form required in accordance with UK MAR is set out below.
Enquiries:
PayPoint Plc
Phil Higgins, on behalf of Indigo Corporate Secretary Limited, Company Secretary
+44 (0)07701061533
Steve O'Neill, Corporate Affairs and Marketing Director
+44 (0)7919488066
LEI: 5493004YKWI8U0GDD138
http://corporate.paypoint.com/
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Rob Harding |
| 2. | Reason for the notification | |
| a) | Position/status | PDMR |
| b) | Initial notification/Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | PayPoint Plc |
| b) | LEI | 5493004YKWI8U0GDD138 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 0.3611 pence ISIN: GB00BVMTNR93 |
| b) | Nature of the transaction | Purchase of Ordinary Shares |
| c) | Prices and volumes | Purchase
|
| d) | Aggregated information | N/A |
| e) | Date of the transaction | 21 November 2025 |
| f) | Place of the transaction | London |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026
- Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform
- Best Crypto Presale to Buy in 2026? Can Remittix’s 300M RTX Burn Plan Outshine Solana and Zcash?
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
